Six cases of spermatocytic seminoma are reported, and the literature on the subject is reviewed. This neoplasm occurs in elderly persons, is grossly characterized by a gelatinous appearance, and has distinctive microscopic characteristics. Its degree of differentiation is far greater than that exhibited by classical seminoma, a tumor from which it should be separated. It is exclusively limited to the testicle and is never associated with teratomatous elements. Claims that it has a less favorable prognosis than classical seminoma are refuted; instead it is shown that the reverse is probably true. The large majority of patients have been cured by orchiectomy, whether or not postoperative irradiation therapy had been administered.
Two cases of spermatocytic seminoma were examined by electron microscopy. The more important ultrastructural features were: prominent nucleolus with dispersed nucleolonema; occasional nuclei with die chromosomal configuration of the leptotene stage of meiotic prophase; marked development of die Golgi apparatus, with formation of a dense secretory product; basal bodies and ciliary rootlets; “lamellar bodies”; specialized cell junctions of the zonula adherens type; true intercellular bridges, identical to those normally found between spermatocytes and between spermatids; syncytial formations; and basal laminae (basement membranes). Comparison of these findings with those of classical seminomas suggests an origin from the same cell type but also indicates that spermatocytic seminoma is a tumor distinct from the former by virtue of its greater differentiation, as evidenced by its capacity to produce spermatocytes and possibly spermatids.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.